EE200000394A - Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu - Google Patents

Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu

Info

Publication number
EE200000394A
EE200000394A EEP200000394A EEP200000394A EE200000394A EE 200000394 A EE200000394 A EE 200000394A EE P200000394 A EEP200000394 A EE P200000394A EE P200000394 A EEP200000394 A EE P200000394A EE 200000394 A EE200000394 A EE 200000394A
Authority
EE
Estonia
Prior art keywords
local anesthetics
new use
against vascular
vascular headaches
headaches
Prior art date
Application number
EEP200000394A
Other languages
English (en)
Estonian (et)
Inventor
Dalsgaard Carl-Johan
Eek Arne
Waldenlind Lennart
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000394A publication Critical patent/EE200000394A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
EEP200000394A 1997-12-19 1998-12-14 Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu EE200000394A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704770A SE9704770D0 (sv) 1997-12-19 1997-12-19 New use
PCT/SE1998/002299 WO1999032103A1 (en) 1997-12-19 1998-12-14 New use of local anaesthetics against vascular headaches

Publications (1)

Publication Number Publication Date
EE200000394A true EE200000394A (et) 2001-12-17

Family

ID=20409476

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000394A EE200000394A (et) 1997-12-19 1998-12-14 Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu

Country Status (18)

Country Link
EP (1) EP1047412A1 (xx)
JP (1) JP2001526217A (xx)
KR (1) KR20010024768A (xx)
CN (1) CN1282241A (xx)
AU (1) AU1898199A (xx)
BR (1) BR9813775A (xx)
CA (1) CA2314452A1 (xx)
EE (1) EE200000394A (xx)
HU (1) HUP0100599A3 (xx)
ID (1) ID26703A (xx)
IL (1) IL136518A0 (xx)
IS (1) IS5534A (xx)
NO (1) NO20003138L (xx)
PL (1) PL341283A1 (xx)
SE (1) SE9704770D0 (xx)
SK (1) SK7832000A3 (xx)
TR (1) TR200001926T2 (xx)
WO (1) WO1999032103A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
WO2000044432A1 (en) 1999-01-27 2000-08-03 Levin Bruce H Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
UA123759C2 (uk) 2014-03-21 2021-06-02 Тева Фармасьютікалз Інтернешнл Гмбх Застосування моноклонального антитіла, яке інгібує шлях пов'язаного з геном кальциноніну пептиду (cgrp), для лікування або зниження частоти випадків мігренозного головного болю у суб'єкта
ES2846878T3 (es) * 2015-09-24 2021-07-30 Teva Pharmaceuticals Int Gmbh Prevenir, tratar y reducir el dolor de cabeza post-traumático (persistente)
US10392434B2 (en) 2016-09-23 2019-08-27 Teva Pharmaceuticals International Gmbh Treating refractory migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380746A (de) * 1958-11-06 1964-08-15 Ciba Geigy Verfahren zur Herstellung neuer sekundärer Amine
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
AR004691A1 (es) * 1995-10-27 1999-03-10 Astrazeneca Ab Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion

Also Published As

Publication number Publication date
ID26703A (id) 2001-02-01
BR9813775A (pt) 2000-10-10
KR20010024768A (ko) 2001-03-26
WO1999032103A1 (en) 1999-07-01
NO20003138L (no) 2000-08-18
JP2001526217A (ja) 2001-12-18
NO20003138D0 (no) 2000-06-16
IL136518A0 (en) 2001-06-14
CN1282241A (zh) 2001-01-31
SK7832000A3 (en) 2001-02-12
PL341283A1 (en) 2001-04-09
TR200001926T2 (tr) 2000-11-21
IS5534A (is) 2000-06-15
AU1898199A (en) 1999-07-12
HUP0100599A2 (hu) 2002-02-28
EP1047412A1 (en) 2000-11-02
HUP0100599A3 (en) 2002-04-29
SE9704770D0 (sv) 1997-12-19
CA2314452A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
EE200000640A (et) Uus kasutamine
EE200000192A (et) Uus kombinatsioon
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE60041145D1 (de) Nutzung von daten
NO20000268D0 (no) Anvendelse av Lactobacillus for reduksjon av fibrinogen nivå
ID18679A (id) Penggunaan terapi lanjutan
EE200000022A (et) Uus ravimvorm
EE200000394A (et) Lokaalanesteetikumide uus kasutamine vaskulaarsete peavalude vastu
IS5996A (is) Notkun á kólesteról lækkandi miðli
IS5814A (is) Ný lyfjafræðileg notkun á NOS lötum
EE9900455A (et) Uus menetlus
ID30381A (id) Penggunaan arilalkanoilpiridazina
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
KR970053464U (ko) 휴지걸이
SE9802023D0 (sv) New therapeutic use
KR970000336U (ko) 라면요리 2·3·4인용 전용냄비
KR960020020U (ko) 휴지걸이
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
DE29804686U1 (de) Hängesessel
SE9801673D0 (sv) New medical use of substituted quinolines
SE9802551D0 (sv) New medical use of substituted quinolines
SE9900878D0 (sv) New composition and use thereof
SE9801370D0 (sv) New use
SE9800472D0 (sv) New use
ATE466535T1 (de) Kryochirurgischer katheter